Cargando…
NEO6860, modality-selective TRPV1 antagonist: a randomized, controlled, proof-of-concept trial in patients with osteoarthritis knee pain
INTRODUCTION: NEO6860 is a TRPV1 antagonist when activated by capsaicin but not by heat or pH, developed to relieve pain without the adverse events reported with non–modality-selective TRPV1 antagonists. OBJECTIVE: The primary Objective of this study was to evaluate the analgesic efficacy and safety...
Autores principales: | Arsenault, Pierre, Chiche, Dan, Brown, William, Miller, Jeffrey, Treister, Roi, Leff, Richard, Walker, Philippe, Katz, Nathaniel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6344137/ https://www.ncbi.nlm.nih.gov/pubmed/30706039 http://dx.doi.org/10.1097/PR9.0000000000000696 |
Ejemplares similares
-
T(2) mapping of the meniscus is a biomarker for early osteoarthritis
por: Eijgenraam, Susanne M., et al.
Publicado: (2019) -
Association of subchondral bone texture on magnetic resonance imaging with radiographic knee osteoarthritis progression: data from the Osteoarthritis Initiative Bone Ancillary Study
por: MacKay, James W., et al.
Publicado: (2018) -
The interrater and test–retest reliability of 3 modalities of quantitative sensory testing in healthy adults and people with chronic low back pain or rheumatoid arthritis
por: Brady, Sophia M., et al.
Publicado: (2023) -
Meniscal body extrusion and cartilage coverage in middle-aged and elderly without radiographic knee osteoarthritis
por: Svensson, Fredrik, et al.
Publicado: (2018) -
The neurologic pain signature responds to nonsteroidal anti-inflammatory treatment vs placebo in knee osteoarthritis
por: López-Solà, Marina, et al.
Publicado: (2022)